Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-01 @ 6:10 PM
Study NCT ID:
NCT00451958
Status:
COMPLETED
Last Update Posted:
2013-03-21
First Post:
2007-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor:
Ferring Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-23
First Submit QC Date:
None
Study First Post Date:
2007-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-10-10
Results First Submit QC Date:
None
Results First Post Date:
2013-03-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-20
Last Update Post Date:
2013-03-21
Last Update Post Date Type:
ESTIMATED